Intellectual Property Reform concerning bio-pharmaceutical industry Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions Trade-Related Aspects of Intellectual Property (TRIPS) Waiver. No related bill number Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions Issues related to the Inflation Reduction Act of 2022 IRA implementation HR 1319, American Rescue Plan Act of 2021 - regarding all bio-pharmaceutical related provisions S 464/HR 2163, Safe Step Act - regarding all bio-pharmaceutical related provisions Proposed reconciliation bill encompassing all pharmaceutical provisions Discussions regarding health equity HR 5376, the Build Back Better Act regarding all bio-pharmaceutical provisions PBM reform including S.4293, Pharmacy Benefit Manager Transparency Act of 2022 H.R.485, Protecting Health Care for All Patients of 2023 Act H.R.830, HELP Copays Act of 2023
CPT - Copyright/Patent/Trademark TAX - Taxation/Internal Revenue Code TRD - Trade (domestic/foreign) MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BRISTOL-MYERS SQUIBB COMPANY
801 Pennsylvania Ave, NW, Suite 745, WASHINGTON, DC, 20004, US
JEFFREY LAST LANE PENRY JOHN DEOUDES PAUL ANTHONY WILLIAMS JOHN DEOUDES RICARDO SANCHEZ ORTEGON PAUL ANTHONY WILLIAMS LANE PENRY STEPHANIE A. DYSON KATHRYN NOVARIA CAROLINE TUCKER JOHN DEOUDES RICARDO SANCHEZ ORTEGON PAUL ANTHONY WILLIAMS LANE PENRY KATHRYN NOVARIA JEFFREY LAST THOMAS BRUNET STEPHANIE A. DYSON JOHN DEOUDES RICARDO SANCHEZ ORTEGON